Literature DB >> 11594775

Matrix metalloproteinase-2 and -9 in bile as a marker of liver metastasis in colorectal cancer.

N Okada1, H Ishida, N Murata, D Hashimoto, Y Seyama, S Kubota.   

Abstract

Matrix metallproteinases (MMP)-2 and -9 are associated with cancer invasion and metastasis. MMP-2 and MMP-9 activities have never been assayed in bile. In the present study we investigated whether MMP-2 and -9 activities in the bile could be a marker for evaluation of liver metastasis in colorectal cancer. Fifty-three patients underwent colorectal resection for histologically verified adenocarcinoma. Twenty-six patients had colorectal cancer without liver metastasis and 27 patients had metastatic liver tumor. Six patients were studied as carcinoma-free control. MMP-2 and MMP-9 activities were assayed in bile using gelatin zymography and quantitated. Active MMP-2 activity of colorectal cancer with liver metastasis group (24.1 +/- 2.5 pixel count) was significantly higher than that of colorectal cancer without liver metastasis group (11.4 +/- 1.3 pixel count) (P < 0.001) or of control group (6.4 +/- 1.0 pixel count) (P < 0.001). Active MMP-9 was not detected in bile. ProMMP-9 activity of colorectal cancer with liver metastasis group (530.3 +/- 127.5 pixel count) was significantly higher than that of colorectal cancer without liver metastasis group (213.9 +/- 33.2 pixel count) (P = 0.008). This is the first report showing that the levels of active MMP-2 and proMMP-9 in bile were significantly higher in liver metastasis of colorectal cancer than in metastasis-free colorectal cancer. The results suggest that activities of active MMP-2 and proMMP-9 in the bile may be useful markers for predicting liver metastasis in colorectal cancer. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594775     DOI: 10.1006/bbrc.2001.5741

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Serum and biliary MMP-9 and TIMP-1 concentrations in the diagnosis of cholangiocarcinoma.

Authors:  Ali Tüzün İnce; Kemal Yıldız; Venkatanarayana Gangarapu; Yusuf Kayar; Birol Baysal; Oğuzhan Karatepe; Ahu Sarbay Kemik; Hakan Şentürk
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Evaluation of neuroprotective effects of insulin on immuno-inflammatory and systemic disorders induced by kaliotoxin, a Kv1.3 channel blocker.

Authors:  Zahida Taibi-Djennah; Marie-France Martin-Eauclaire; Fatima Laraba-Djebari
Journal:  Inflamm Res       Date:  2018-08-06       Impact factor: 4.575

3.  Application of multiplex arrays for cytokine and chemokine profiling of bile.

Authors:  Troy J Kemp; Felipe A Castro; Yu-Tang Gao; Allan Hildesheim; Leticia Nogueira; Bing-Sheng Wang; Lu Sun; Gloriana Shelton; Ruth M Pfeiffer; Ann W Hsing; Ligia A Pinto; Jill Koshiol
Journal:  Cytokine       Date:  2015-03-02       Impact factor: 3.861

Review 4.  Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.

Authors:  Fang Bao; Jiayue Liu; Haiyang Chen; Lu Miao; Zhaochao Xu; Guixin Zhang
Journal:  Cancers (Basel)       Date:  2022-08-13       Impact factor: 6.575

5.  The CXCL12/CXCR4 autocrine loop increases the metastatic potential of non-small cell lung cancer in vitro.

Authors:  Xiaofeng Dai; Zhifu Mao; Jie Huang; Songping Xie; Hao Zhang
Journal:  Oncol Lett       Date:  2012-10-10       Impact factor: 2.967

6.  Role of Leptin in Neoplastic and Biliary Tree Disease.

Authors:  Paolo Izzo; Sara Izzo; Pierfrancesco DI Cello; Gabriele D'Amata; Maurizio Cardi; Andrea Polistena; Daniela Messineo; Luciano Izzo
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

7.  Isolation and characterization of chicken bile matrix metalloproteinase.

Authors:  B Packialakshmi; R Liyanage; K S Rasaputra; Jackson O Lay; N C Rath
Journal:  Poult Sci       Date:  2014-06       Impact factor: 3.352

8.  The oxygen free radicals control MMP-9 and transcription factors expression in the spontaneously hypertensive rat.

Authors:  Naphatsanan Duansak; Geert W Schmid-Schönbein
Journal:  Microvasc Res       Date:  2013-09-21       Impact factor: 3.514

9.  Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells.

Authors:  Ming-Ju Hsieh; Chiao-Wen Lin; Shun-Fa Yang; Mu-Kuan Chen; Hui-Ling Chiou
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

10.  CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.

Authors:  Jianhua Wang; Yi Lu; Jingchen Wang; Alisa E Koch; Jian Zhang; Russell S Taichman
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.